Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001209191-21-049657 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-04 | 2021-08-03 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $178.03 | -15.0K | 912.9K | -2% | -$2.67M |
| DM | 2021-08-04 | 2021-08-03 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $9.24 | +15.0K | 919.1K | +2% | +$138.7K |
| DM | 2021-08-04 | 2021-08-03 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -15.0K | 74.2K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-03 | S | D | 1,700 | $176.52 | 917,368 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $175.995 to $176.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-08-03 | S | D | 7,946 | $178.47 | 904,972 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $178.00 to $178.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-08-03 | S | D | 904 | $179.35 | 904,068 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $179.03 to $179.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-08-03 | S | D | 4,450 | $177.56 | 912,918 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $177.00 to $177.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-08-03 | M | A | 5,208 | $5.04 | 909,276 | D | — | — | |
| 6 | Common | Class A Common Stock | 2021-08-03 | M | A | 9,792 | $11.48 | 919,068 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2021-08-03 | M | D | 9,792 | $0.00 | 67,921 | D | $11.48 · — to 2029-05-10 | 9,792 Class A Common Stock | (F8) This option, originally for 145,786 shares, of which 77,865 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 8 | Derivative | Stock Option (right to buy) | 2021-08-03 | M | D | 5,208 | $0.00 | 74,157 | D | $5.04 · — to 2028-11-02 | 5,208 Class A Common Stock | (F7) This option, originally for 250,000 shares, of which 175,843 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |